4//SEC Filing
Talbot George Harrison 4
Accession 0001104659-17-060014
CIK 0001641640other
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 7:34 PM ET
Size
7.1 KB
Accession
0001104659-17-060014
Insider Transaction Report
Form 4
Talbot George Harrison
Director
Transactions
- Exercise/Conversion
Stock Option
2017-09-27−1,350→ 0 totalExp: 2017-09-27→ Ordinary Shares (1,350 underlying) - Exercise/Conversion
Ordinary Shares
2017-09-27+1,350→ 33,140 total
Footnotes (3)
- [F1]Dr. Talbot exercised his remaining stock options under the Company's Stock Option Plan 2007, which were set to expire on September 27, 2017. Dr. Talbot paid the exercise price in cash.
- [F2]The exercise price was .672 euros per share.
- [F3]These options were granted on various dates between 2009 and 2014 and are fully vested.
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001554194
Filing Metadata
- Form type
- 4
- Filed
- Sep 28, 8:00 PM ET
- Accepted
- Sep 29, 7:34 PM ET
- Size
- 7.1 KB